Back to Archived Journals » Core Evidence » Volume 1-Issues 3 & 4 » Issue 3
Core Evidence ceased publishing in January 2023. All articles that have been published in Core Evidence will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.
Core Evidence
ISSN: 1555-175X
- View all (143)
- Volume 15, 2020 (4)
- Volume 14, 2019 (6)
- Volume 13, 2018 (3)
- Volume 12, 2017 (2)
- Volume 11, 2016 (5)
- Volume 10, 2015 (9)
- Volume 9, 2014 (13)
- Volume 8, 2013 (7)
- Volume 7, 2012 (12)
- Volume 6, 2011 (7)
- Volume 5, 2010 (9)
- Volume 4, 2009 (20)
- Volume 3, 2008 (5)
- Volume 2, 2007 (22)
- Volume 1-Issues 3 & 4, 2006 (8)
- Volume 1-Issues 1 & 2, 2005 (11)
Archive: Volume 1-Issues 3 & 4, 2006
K-111: the emerging evidence for its potential in the treatment of the metabolic syndrome
Margaret Duggan-Keen
Core Evidence 2006, 1-Issues 3 & 4:0-0
Published Date: 31 March 2006
Tigecycline: an evidence-based review of its antibacterial activity and effectiveness in complicated skin and soft tissue and intraabdominal infections
Christopher J. Dunn
Core Evidence 2006, 1-Issues 3 & 4:0-0
Published Date: 31 March 2006
Donepezil in Alzheimer’s disease: an evidence-based review of its impact on clinical and economic outcomes
Joanne Knowles
Core Evidence 2006, 1-Issues 3 & 4:0-0
Published Date: 31 March 2006
FTY720 in multiple sclerosis: the emerging evidence of its therapeutic value
Andrew Thomson
Core Evidence 2006, 1-Issues 3 & 4:0-0
Published Date: 31 March 2006